Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
Abstract Background Current research underscores the need to better understand the pathogenic mechanisms and treatment strategies for idiopathic pulmonary fibrosis (IPF). This study aimed to identify key targets involved in the progression of IPF. Methods We employed Mendelian randomization (MR) wit...
Saved in:
Main Authors: | Zhe Chen, Mingyang Tang, Nan Wang, Jiangjiang Liu, Xiaoyan Tan, Haitao Ma, Jing Luo, Kai Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-025-03848-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025-01-01) -
Quality of life in idiopathic pulmonary fibrosis in Latin American countries
by: H. Aguilar-Duran, et al.
Published: (2025-01-01) -
Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01) -
Identification and Analysis of Key Immune- and Inflammation-Related Genes in Idiopathic Pulmonary Fibrosis
by: Tan Y, et al.
Published: (2025-02-01) -
Machine learning potential predictor of idiopathic pulmonary fibrosis
by: Chenchun Ding, et al.
Published: (2025-01-01)